Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
32.59
-2.41 (-6.89%)
At close: May 22, 2026, 4:00 PM EDT
33.13
+0.54 (1.66%)
After-hours: May 22, 2026, 7:49 PM EDT
Eton Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Eton Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $42.67. The average 1-year stock price forecast is 30.93% higher than the current stock price, while the lowest is $31 (-4.88%) and the highest is $57 (+74.90%).
Price Target: $42.67 (+30.93%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Eton Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $52 → $57 | Strong Buy | Maintains | $52 → $57 | +74.90% | May 15, 2026 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $26 → $31 | Strong Buy | Maintains | $26 → $31 | -4.88% | Mar 20, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $37 → $52 | Strong Buy | Maintains | $37 → $52 | +59.56% | Mar 20, 2026 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $30 → $35 | Strong Buy | Maintains | $30 → $35 | +7.39% | Mar 20, 2026 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $29 → $30 | Strong Buy | Maintains | $29 → $30 | -7.95% | Mar 3, 2026 |
Financial Forecast
Revenue This Year
119.73M
from 79.95M
Increased by 49.76%
Revenue Next Year
181.68M
from 119.73M
Increased by 51.74%
EPS This Year
0.82
from -0.17
EPS Next Year
2.03
from 0.82
Increased by 148.75%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 127.3M | 189.4M | ||||||
| Avg | 119.7M | 181.7M | ||||||
| Low | 108.6M | 173.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 59.2% | 58.2% | ||||||
| Avg | 49.8% | 51.7% | ||||||
| Low | 35.9% | 44.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.10 | 2.22 | |
| Avg | 0.82 | 2.03 | |
| Low | 0.59 | 1.84 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 171.5% | |
| Avg | - | 148.7% | |
| Low | - | 125.8% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.